India's Natco Pharma up as FDA's inspection ends with zero observations

Natco Pharma

02/11/2023 06:03

** Shares of Natco Pharma  NATP.NS  rise as much as 4.34% to
773.75 rupees, most intraday pct gain in over six weeks
    ** Drug maker says U.S. Food and Drug Administration (USFDA)
completed probe on Natco's compliance to pharmacovigilance
requirements with zero observations
    ** Inspection conducted at NATP's pharmacovigilance
department at its corporate office in Hyderabad
    ** Trading volume at 870,314 shares as of 11:18 a.m. IST,
more than twice the 30-day avg - LSEG data
    ** NATP among top gainers in pharma index  .NIPHARM , which
is up 1%
    ** Including day's gains, NATP has risen 33.50% in 2023 so
far, compared with 18% rise in pharma index

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))